Laparoscopic Resection May Be An Option for CRC Liver Metastases
TUESDAY, Nov. 17, 2020 (HealthDay News) — For patients with metastatic colorectal cancer who...
Read More
Hematology/Oncology
Triplet Therapy Slows Refractory Multiple Myeloma
WEDNESDAY, Nov. 18, 2020 (HealthDay News) — A once-weekly regimen of selinexor, bortezomib,...
Read More
Vitamin D Supplementation Tied to Reduction in Advanced Cancer
WEDNESDAY, Nov. 18, 2020 (HealthDay News) — Vitamin D supplementation is associated with a...
Read More
ASTRO Issues Guideline on Radiation Therapy for Rectal Cancer
MONDAY, Oct. 26, 2020 (HealthDay News) — In a clinical practice guideline issued by the...
Read More
Rurality, Income Impact Stage at Diagnosis, Mortality in Liver Cancer
MONDAY, Oct. 26, 2020 (HealthDay News) — Patients with hepatocellular carcinoma (HCC) from...
Read More
Convalescent Plasma Has Limited Benefit for Moderate COVID-19
FRIDAY, Oct. 23, 2020 (HealthDay News) — For patients with moderate COVID-19, convalescent...
Read More
MRI Safe for Those With Non-MRI-Conditional Cardiac Devices
FRIDAY, Oct. 23, 2020 (HealthDay News) — Magnetic resonance imaging (MRI) can be safely...
Read More
SHEA Updates Guidance for Health Care Staff With Hepatitis, HIV
FRIDAY, Oct. 23, 2020 (HealthDay News) — In a Society for Healthcare Epidemiology of America...
Read More
Breast Cancer Surgery Feasible for Most Fit Older Women
FRIDAY, Oct. 23, 2020 (HealthDay News) — The majority of older women can tolerate surgery...
Read More
American College of Surgeons, Oct. 3-7
The 105th Annual American College of Surgeons Clinical Congress The annual meeting of the American...
Read More
Dasatinib + Blinatumomab Active for Ph-Positive ALL in Adults
THURSDAY, Oct. 22, 2020 (HealthDay News) — Chemotherapy-free induction and consolidation...
Read More
Taking Lipid-Lowering Meds Tied to Lower Risk for Cancer Death
THURSDAY, Oct. 22, 2020 (HealthDay News) — For women with breast cancer, colorectal cancer,...
Read MoreDasatinib + Blinatumomab Active for Ph-Positive ALL in Adults
THURSDAY, Oct. 22, 2020 (HealthDay News) — Chemotherapy-free induction and consolidation first-line treatment with dasatinib and blinatumomab is associated with a high incidence of molecular response and survival in adults...
Read More
Rate of Injuries Increased Around Diagnosis of Cervical Cancer
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Women with invasive cervical cancer (ICC) have...
Read More
Insurance Tied to Odds of Cancer Surgery at High-Volume Centers
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Uninsured, Medicare-insured, and...
Read More
Interval Breast Cancers Tied to Worse Outcomes
WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Interval breast cancers (IBCs) account for...
Read More
More Physical Activity, Less Sitting Beneficial for Seniors
TUESDAY, Oct. 20, 2020 (HealthDay News) — For older adults, more moderate- to...
Read More
CDC: One-Year Survival 96.1 Percent for Male Breast Cancer
TUESDAY, Oct. 20, 2020 (HealthDay News) — For men with a diagnosis of breast cancer during...
Read More
Linked Color Imaging Detects More Neoplastic Upper GI Lesions
TUESDAY, Oct. 20, 2020 (HealthDay News) — Linked color imaging (LCI) can detect neoplastic...
Read More
Electronic Cigarettes Improve Long-Term Smoking Cessation
MONDAY, Oct. 19, 2020 (HealthDay News) — Nicotine electronic cigarettes (ECs) improve...
Read More